Haegarda and LarkaDrin Capsules
Determining the interaction of Haegarda and LarkaDrin Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Haegarda, Berinert, Cinryze, Ruconest
Synonyms: n.a.
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Haegarda-Laronidase
- Haegarda-Laronidase Intravenous
- Haegarda-Larotrectinib
- Haegarda-Larotrectinib Capsules
- Haegarda-Larotrectinib Oral Solution
- Haegarda-Larotrectinib Sulfate
- LarkaDrin Capsules-Haemonetics Anticoagulant Sodium Citrate
- LarkaDrin Capsules-Haemophilus b conjugate (PRP-OMP) vaccine
- LarkaDrin Capsules-Haemophilus b conjugate (PRP-T) vaccine
- LarkaDrin Capsules-Haemophilus b conjugate and hepatitis b vaccine Intramuscular
- LarkaDrin Capsules-Haemophilus b Conjugate Vaccine
- LarkaDrin Capsules-Haemophilus b conjugate vaccine Intramuscular